Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · IEX Real-Time Price · USD
46.59
-4.19 (-8.25%)
At close: Apr 18, 2024, 4:00 PM
48.91
+2.32 (4.98%)
After-hours: Apr 18, 2024, 6:57 PM EDT
PRAX Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PRAX stock have an average target of 103, with a low estimate of 29 and a high estimate of 150. The average target predicts an increase of 121.08% from the current stock price of 46.59.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $75 → $128 | Strong Buy | Maintains | $75 → $128 | +174.74% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +125.37% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +125.37% | Mar 6, 2024 |
| Wedbush | Wedbush | Hold Maintains $16 → $29 | Hold | Maintains | $16 → $29 | -37.75% | Jan 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +125.37% | Dec 5, 2023 |
Financial Forecast
Revenue This Year
2.35M
from 2.45M
Decreased by -4.13%
Revenue Next Year
1.50M
from 2.35M
Decreased by -35.98%
EPS This Year
-9.16
from -18.69
EPS Next Year
-9.85
from -9.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 6.1M | 268.7M | 599.3M | 1.1B |
| Avg | 2.3M | 1.5M | 82.9M | 181.2M | 385.9M |
| Low | n/a | n/a | 784,000 | 7.4M | 56.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 114.5% | 161.2% | 17,790.1% | 622.9% | 499.5% |
| Avg | -4.1% | -36.0% | 5,419.2% | 118.5% | 113.0% |
| Low | - | - | -47.8% | -91.1% | -69.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.63 | -6.48 | 4.49 | 31.03 | 63.47 |
| Avg | -9.16 | -9.85 | -5.91 | 0.76 | 17.78 |
| Low | -9.85 | -12.67 | -15.92 | -14.71 | -2.82 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 8,224.8% |
| Avg | - | - | - | - | 2,231.8% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.